Legend Biotech Corporation (LEGN) stock analysis
In our weekly check, Legend Biotech Corporation is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 11 pass, warnings: 2, red flags: 9.
About Legend Biotech Corporation
Legend Biotech Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as LEGN.
What our checks show for LEGN
Red flags
- The gross margin fell by 43 points, to 57%: costs are rising faster than prices.
- Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
- Earnings per share fell 84.7% a year over the last 3 years.
- The net margin is only 0%: little room if costs rise.
- Free cash flow is negative (-23.6% of revenue): the business spends more cash than it brings in.
- The price swings a lot: 73.4% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 78% from a peak. Would you have held through that?
- Return on capital (ROCE) is only 2.4%.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- Operating profit covers interest only 2.3 times: a weak year could make the payments hard.
- The stock is still below its previous peak.
Strengths
- Debt is low: 0.13x equity.
- The net margin rose by 586 points over 5 years, to 0%.
- Analysts expect earnings per share to grow about 643% a year over the next years.
- Analysts expect revenue to grow about 15.8% a year over the next years.
- Analysts expect the net margin to improve by 9 points from today's 0%.
- Revenue grew 126% a year over the last 3 years.
Similar companies
ACAD · DYN · CELC · IDYA · IRON · XERS
Questions
What grade does Legend Biotech Corporation (LEGN) have?
In our weekly check, Legend Biotech Corporation is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 11 pass, warnings: 2, red flags: 9. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of LEGN stock?
This week's biggest flags for Legend Biotech Corporation: Gross margin falling, Profits not backed by cash, Weak EPS growth. In total 11 of 22 checks show a warning or a red flag.
What does Legend Biotech Corporation do?
Legend Biotech Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as LEGN.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis